- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 513/06 - Peri-condensed systems
Patent holdings for IPC class C07D 513/06
Total number of patents in this class: 87
10-year publication summary
6
|
14
|
10
|
5
|
5
|
6
|
1
|
7
|
15
|
2
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Merck Patent GmbH | 5909 |
7 |
Erasca, Inc. | 67 |
7 |
LG Chem, Ltd. | 17205 |
5 |
Onkure, Inc. | 21 |
4 |
Glaxo Group Limited | 4496 |
3 |
Samsung Display Co., Ltd. | 30585 |
3 |
FUJIFILM Corporation | 27102 |
3 |
Piramal Enterprises Limited | 156 |
3 |
Promega Corporation | 548 |
3 |
Shionogi & Co., Ltd. | 914 |
3 |
Bayer Pharma AG | 1096 |
2 |
Amgen Inc. | 3779 |
2 |
Abbvie Inc. | 1808 |
2 |
Bioimics AB | 3 |
2 |
Council of Scientific and Industrial Research | 670 |
2 |
Prelude Therapeutics, Incorporated | 102 |
2 |
Samsung Electronics Co., Ltd. | 131630 |
1 |
The Regents of the University of California | 18943 |
1 |
Janssen Pharmaceutica N.V. | 3839 |
1 |
Canon Inc. | 36841 |
1 |
Other owners | 30 |